{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T21:36:32Z","timestamp":1776202592294,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T00:00:00Z","timestamp":1285027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T00:00:00Z","timestamp":1285027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00403-010-1080-1","type":"journal-article","created":{"date-parts":[[2010,9,20]],"date-time":"2010-09-20T11:38:32Z","timestamp":1284982712000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":696,"title":["Definition of treatment goals for moderate to severe psoriasis: a European consensus"],"prefix":"10.1007","volume":"303","author":[{"given":"U.","family":"Mrowietz","sequence":"first","affiliation":[]},{"given":"K.","family":"Kragballe","sequence":"additional","affiliation":[]},{"given":"K.","family":"Reich","sequence":"additional","affiliation":[]},{"given":"P.","family":"Spuls","sequence":"additional","affiliation":[]},{"given":"C. E. M.","family":"Griffiths","sequence":"additional","affiliation":[]},{"given":"A.","family":"Nast","sequence":"additional","affiliation":[]},{"given":"J.","family":"Franke","sequence":"additional","affiliation":[]},{"given":"C.","family":"Antoniou","sequence":"additional","affiliation":[]},{"given":"P.","family":"Arenberger","sequence":"additional","affiliation":[]},{"given":"F.","family":"Balieva","sequence":"additional","affiliation":[]},{"given":"M.","family":"Bylaite","sequence":"additional","affiliation":[]},{"given":"O.","family":"Correia","sequence":"additional","affiliation":[]},{"given":"E.","family":"Daud\u00e9n","sequence":"additional","affiliation":[]},{"given":"P.","family":"Gisondi","sequence":"additional","affiliation":[]},{"given":"L.","family":"Iversen","sequence":"additional","affiliation":[]},{"given":"L.","family":"Kem\u00e9ny","sequence":"additional","affiliation":[]},{"given":"M.","family":"Lahfa","sequence":"additional","affiliation":[]},{"given":"T.","family":"Nijsten","sequence":"additional","affiliation":[]},{"given":"T.","family":"Rantanen","sequence":"additional","affiliation":[]},{"given":"A.","family":"Reich","sequence":"additional","affiliation":[]},{"given":"T.","family":"Rosenbach","sequence":"additional","affiliation":[]},{"given":"S.","family":"Segaert","sequence":"additional","affiliation":[]},{"given":"C.","family":"Smith","sequence":"additional","affiliation":[]},{"given":"T.","family":"Talme","sequence":"additional","affiliation":[]},{"given":"B.","family":"Volc-Platzer","sequence":"additional","affiliation":[]},{"given":"N.","family":"Yawalkar","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,9,21]]},"reference":[{"key":"1080_CR1","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000119415","volume":"216","author":"M Augustin","year":"2008","unstructured":"Augustin M, Kr\u00fcger K, Radtke MA et al (2008) Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology 216:366\u2013372","journal-title":"Dermatology"},{"key":"1080_CR2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.clinthera.2009.06.005","volume":"31","author":"MJ Bergman","year":"2009","unstructured":"Bergman MJ (2009) Assessing adequate treatment response in patients with rheumatoid arthritis. Clin Ther 31:1219\u20131231","journal-title":"Clin Ther"},{"key":"1080_CR3","doi-asserted-by":"publisher","first-page":"b5666","DOI":"10.1136\/bmj.b5666","volume":"340","author":"WH Boehncke","year":"2010","unstructured":"Boehncke WH, Boehncke S, Sch\u00f6n MP (2010) Managing comorbid disease in patients with psoriasis. BMJ 340:b5666","journal-title":"BMJ"},{"key":"1080_CR4","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1038\/sj.jid.5701142","volume":"127","author":"H Both","year":"2007","unstructured":"Both H, Essink-Bot ML, Busschbach J, Nijsten T (2007) Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol 127:2726\u20132739","journal-title":"J Invest Dermatol"},{"key":"1080_CR5","first-page":"4","volume":"81","author":"SB Cohen","year":"2008","unstructured":"Cohen SB, Cohen MD, Cush JJ et al (2008) Unresolved issues in identifying, overcoming inadequate response in rheumatoid arthritis: weighing the evidence. J Rheumatol Suppl 81:4\u201330","journal-title":"J Rheumatol Suppl"},{"key":"1080_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1365-2133.2006.07405.x","volume":"155","author":"L Dubertret","year":"2006","unstructured":"Dubertret L, Mrowietz U, Ranki A et al (2006) EUROPSO patient survey 2006. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 155:729\u2013736","journal-title":"Br J Dermatol"},{"key":"1080_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK (1994) Dermatology life quality index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210\u2013216","journal-title":"Clin Exp Dermatol"},{"key":"1080_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2133.2005.06502.x","volume":"152","author":"AY Finlay","year":"2005","unstructured":"Finlay AY (2005) Current severe psoriasis, the rule of tens. Br J Dermatol 152:861\u2013867","journal-title":"Br J Dermatol"},{"key":"1080_CR9","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/j.1368-5031.2005.00680.x","volume":"59","author":"SE Gillard","year":"2005","unstructured":"Gillard SE, Finlay AY (2005) Current management of psoriasis in the United Kingdom: patterns of prescribing, resource use in primary care. Int J Clin Pract 59:1260\u20131267","journal-title":"Int J Clin Pract"},{"key":"1080_CR10","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","volume":"32","author":"F Hasson","year":"2000","unstructured":"Hasson F, Keeney S, McKenna H (2000) Research guidelines for the Delphi survey technique. J Adv Nurs 32:1008\u20131015","journal-title":"J Adv Nurs"},{"key":"1080_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","volume":"125","author":"Y Hongbo","year":"2005","unstructured":"Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY (2005) Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 125:659\u2013664","journal-title":"J Invest Dermatol"},{"key":"1080_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00403-007-0744-y","volume":"299","author":"A Nast","year":"2007","unstructured":"Nast A, Kopp I, Augustin M et al (2007) German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version). Arch Dermatol Res 299:111\u2013138","journal-title":"Arch Dermatol Res"},{"key":"1080_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00403-009-0978-y","volume":"301","author":"A Nast","year":"2009","unstructured":"Nast A, Erdmann R, Hofelich V et al (2009) Do guidelines change the way we treat? Studying private practitioners\u2019 prescription behaviour before and after the publication of the German Psoriasis Guidelines. Arch Dermatol Res 301:553\u2013559","journal-title":"Arch Dermatol Res"},{"key":"1080_CR14","doi-asserted-by":"crossref","unstructured":"Nestle FO, Kaplan DH, Barker JN (2009) Psoriasis. N Engl J Med 361:496\u2013509","DOI":"10.1056\/NEJMra0804595"},{"key":"1080_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/archderm.143.2.239","volume":"143","author":"DM Pariser","year":"2007","unstructured":"Pariser DM, Bagel J, Gelfand JM et al (2007) National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol 143:239\u2013242","journal-title":"Arch Dermatol"},{"issue":"Suppl 2","key":"1080_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-3083.2009.03389.x","volume":"23","author":"D Pathirana","year":"2009","unstructured":"Pathirana D, Ormerod AD, Saiag P et al (2009) European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 23(Suppl 2):1\u201370","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1080_CR17","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S0140-6736(05)67566-6","volume":"366","author":"K Reich","year":"2005","unstructured":"Reich K, Nestle FO, Papp K et al (2005) Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet 366:1367\u20131374","journal-title":"Lancet"},{"key":"1080_CR18","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1610-0387.2007.06343.x","volume":"5","author":"K Reich","year":"2007","unstructured":"Reich K, Mrowietz U (2007) Treatment goals in psoriasis. J Dtsch Dermatol Ges 5:566\u2013574","journal-title":"J Dtsch Dermatol Ges"},{"key":"1080_CR19","first-page":"603","volume":"7","author":"K Reich","year":"2009","unstructured":"Reich K, Thaci D, Mrowietz U (2009) Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis\u2014a retrospective study (FUTURE). J Dtsch Dermatol Ges 7:603\u2013611","journal-title":"J Dtsch Dermatol Ges"},{"key":"1080_CR20","first-page":"581","volume":"41","author":"HL Richards","year":"1999","unstructured":"Richards HL, Fortune DG, O\u2019Sullivan TM et al (1999) Patients with psoriasis and their compliance with medication. J Am Acad Dermatol 41:581\u2013583","journal-title":"J Am Acad Dermatol"},{"key":"1080_CR21","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1365-2133.2007.08315.x","volume":"158","author":"JH Saurat","year":"2008","unstructured":"Saurat JH, Stingl G, Dubertret L et al (2008) Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol 158:558\u2013566","journal-title":"Br J Dermatol"},{"key":"1080_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/ard.2009.108472","volume":"69","author":"M Schoels","year":"2010","unstructured":"Schoels M, Aletaha D, Smolen JS et al (2010) Follow-up standards and treatment targets in Rheumatoid Arthritis (RA): results of a questionnaire at the EULAR 2008. Ann Rheum Dis 69:575\u2013578","journal-title":"Ann Rheum Dis"},{"key":"1080_CR23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1365-2133.2005.06893.x","volume":"153","author":"CH Smith","year":"2005","unstructured":"Smith CH, Anstey AV, Barker JN et al (2005) British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol 153:486\u2013497","journal-title":"Br J Dermatol"},{"key":"1080_CR24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1365-2133.2009.09505.x","volume":"161","author":"CH Smith","year":"2009","unstructured":"Smith CH, Anstey AV, Barker JN et al (2009) British Association of Dermatologists\u2019 guidelines for biologic interventions for psoriasis. Br J Dermatol 161:987\u20131019","journal-title":"Br J Dermatol"},{"key":"1080_CR25","first-page":"2121","volume":"148","author":"PI Spuls","year":"2004","unstructured":"Spuls PI, Tuut MK, van Everdingen JJ et al (2004) Werkgroep Psoriasis van de Nederlandse Vereniging voor Dermatologie en Venereologie. The practice guideline photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis. Ned Tijdschr Geneeskd 148:2121\u20132125","journal-title":"Ned Tijdschr Geneeskd"},{"key":"1080_CR26","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/jid.2009.391","volume":"130","author":"PI Spuls","year":"2010","unstructured":"Spuls PI, Lecluse LL, Poulsen ML et al (2010) How good are clinical severity and outcome measures for psoriasis? Quantitative evaluation in a systematic review. J Invest Dermatol 130:933\u2013943","journal-title":"J Invest Dermatol"},{"key":"1080_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaad.2008.03.045","volume":"59","author":"A Storm","year":"2008","unstructured":"Storm A, Andersen SE, Benfeldt E, Serup J (2008) One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol 59:27\u201333","journal-title":"J Am Acad Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-010-1080-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-010-1080-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00403-010-1080-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-010-1080-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T16:22:53Z","timestamp":1711815773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-010-1080-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,21]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["1080"],"URL":"https:\/\/doi.org\/10.1007\/s00403-010-1080-1","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,21]]},"assertion":[{"value":"20 August 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}